A group of prominent media companies and online advertisers have paid a record $10.6 million to kill ads for Clanton, a pharmaceutical company that has become a target of federal regulators.
Clanton, which makes a drug for Parkinson’s and Alzheimer’s, has faced criticism for a string of false and misleading ads.
In the wake of the federal crackdown on the company, the companies said they would pay a one-time $10,000 settlement to the Federal Trade Commission to recoup $1.1 million they were owed by Clanton.
Clampons lawyers said the settlement included no admission of wrongdoing and was “an attempt to put a stop to the continued harassment and attacks on Clanton” by the Federal Communications Commission and other federal agencies.
The companies did not immediately respond to a request for comment on the settlement.